{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:20:41Z","timestamp":1787797241439,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008398","name":"Villum Foundation","doi-asserted-by":"publisher","award":["00025302"],"award-info":[{"award-number":["00025302"]}],"id":[{"id":"10.13039\/100008398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["899987"],"award-info":[{"award-number":["899987"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["850974"],"award-info":[{"award-number":["850974"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W019353\/1"],"award-info":[{"award-number":["MR\/W019353\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","award":["221702\/Z\/20\/Z"],"award-info":[{"award-number":["221702\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.tibtech.2025.10.017","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:13:10Z","timestamp":1763979190000},"page":"724-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intramuscular delivery of mRNA-encoded single-chain variable fragments prevents myotoxin II-induced skeletal muscle damage in a preclinical model"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4637-4468","authenticated-orcid":false,"given":"Jos\u00e9 R.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-936X","authenticated-orcid":false,"given":"Christoffer V.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Gilabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarred","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husain Bin","family":"Haidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0760-6429","authenticated-orcid":false,"given":"Mark","family":"von B\u00fclow M\u00f8iniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Benard-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0272-6150","authenticated-orcid":false,"given":"Esperanza","family":"Rivera-de-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Urquhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2419-6469","authenticated-orcid":false,"given":"Bruno","family":"Lomonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6918-5574","authenticated-orcid":false,"given":"Andreas H.","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-6517","authenticated-orcid":false,"given":"Sakthivel","family":"Vaiyapuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2025.10.017_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000569","article-title":"Snake envenoming: a disease of poverty","volume":"3","author":"Harrison","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0010","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0015","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2023-0057","article-title":"Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies","volume":"29","author":"Thumtecho","year":"2023","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107821","article-title":"Histopathological changes of mice tissues in course of the envenomation by the Macrovipera lebetina obtusa venom and the neutralizing effect of the ovine-derived experimental antivenom","volume":"247","author":"Avagyan","year":"2024","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02725623","article-title":"Surgical implications of snakebites","volume":"71","author":"Chattopadhyay","year":"2004","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2021.100079","article-title":"Clinical management of snakebite envenoming: future perspectives","volume":"11","author":"Hamza","year":"2021","journal-title":"Toxicon X"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.it.2024.03.001","article-title":"Recombinant snake antivenoms get closer to the clinic","volume":"45","author":"Laustsen","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pharmtox-022024-033544","article-title":"Progress and challenges in the field of snakebite envenoming therapeutics","volume":"65","author":"Guti\u00e9rrez","year":"2024","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e25531","article-title":"Revolutionizing snakebite care with novel antivenoms: breakthroughs and barriers","volume":"10","author":"Uko","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-023-36393-4","article-title":"Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain \u03b1-neurotoxins from snakes","volume":"14","author":"Ledsgaard","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0060","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-024-48539-z","article-title":"In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model","volume":"15","author":"Benard-Valle","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0065","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2522838","article-title":"Discovery of broadly neutralizing VHHs against short-chain \u03b1-neurotoxins using a consensus toxin as an antigen","volume":"17","author":"Damsbo","year":"2025","journal-title":"mAbs"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s42004-025-01600-4","article-title":"Structural mechanisms behind the neutralisation of long-chain \u03b1-neurotoxins by broadly neutralising VHHs discovered using a consensus antigen","volume":"8","author":"Damsbo","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0075","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0080","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","article-title":"mRNA vaccines in disease prevention and treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2023.03.039","article-title":"Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures","volume":"357","author":"Meulewaeter","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107024","article-title":"Lys49 myotoxins, secreted phospholipase A(2)-like proteins of viperid venoms: a comprehensive review","volume":"224","author":"Lomonte","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0041-0101(94)90020-5","article-title":"The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study","volume":"32","author":"Lomonte","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0041-0101(87)90078-X","article-title":"Antibody neutralization of a myotoxin from the venom of Bothrops asper (terciopelo)","volume":"25","author":"Lomonte","year":"1987","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade1444","article-title":"Ionizable lipid nanoparticles deliver mRNA to pancreatic \u03b2 cells via macrophage-mediated gene transfer","volume":"9","author":"Melamed","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0120","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/dmd.122.000980","article-title":"Biodistribution of lipid 5, mRNA, and its translated protein following intravenous administration of mRNA-encapsulated lipid nanoparticles in rats","volume":"51","author":"Ci","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/2044-5040-1-34","article-title":"Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders","volume":"1","author":"Mamchaoui","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0130","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.devcel.2024.03.017","article-title":"Three-dimensional imaging studies in mice identify cellular dynamics of skeletal muscle regeneration","volume":"59","author":"Collins","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk1867","article-title":"Synthetic development of a broadly neutralizing antibody against snake venom long-chain \u03b1-neurotoxins","volume":"16","author":"Khalek","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0140","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1038\/s41598-024-53366-9","article-title":"Differential effects of the venoms of Russell's viper and Indian cobra on human myoblasts","volume":"14","author":"Bin Haidar","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/toxins10050182","article-title":"Why is skeletal muscle regeneration impaired after myonecrosis induced by viperid snake venoms?","volume":"10","author":"Guti\u00e9rrez","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/toxins15090530","article-title":"Intramuscular bleeding and formation of microthrombi during skeletal muscle damage caused by a snake venom metalloprotease and a cardiotoxin","volume":"15","author":"Sonavane","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/9caa2be8-b5e6-4553-8575-f0b575442172","article-title":"Poor regenerative outcome after skeletal muscle necrosis induced by Bothrops asper venom: alterations in microvasculature and nerves","volume":"6","author":"Hern\u00e1ndez","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004599","article-title":"Muscle tissue damage induced by the venom of Bothrops asper: identification of early and late pathological events through proteomic analysis","volume":"10","author":"Herrera","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0165","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0041-0101(89)90039-1","article-title":"A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo)","volume":"27","author":"Lomonte","year":"1989","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0170","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.bbapap.2014.09.015","article-title":"A structure-based proposal for a comprehensive myotoxic mechanism of phospholipase A2-like proteins from viperid snake venoms","volume":"1844","author":"Fernandes","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0175","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA vaccines for infectious diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0180","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1038\/s41467-023-43798-8","article-title":"A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection","volume":"14","author":"Tai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0185","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/v14030540","article-title":"Antibodies to crucial epitopes on HSV-2 glycoprotein D as a guide to dosing an mRNA genital herpes vaccine","volume":"14","author":"Hook","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0200","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticlesfrom liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.toxicon.2022.03.008","article-title":"Traces of Bothrops snake venoms in necrotic muscle preclude myotube formation in vitro","volume":"211","author":"Van de Velde","year":"2022","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0210","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/pr800332p","article-title":"Snake venomics of the lancehead pitviper Bothrops asper: geographic, individual, and ontogenetic variations","volume":"7","author":"Alape-Gir\u00f3n","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109846","article-title":"Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo","volume":"9","author":"Mora-Obando","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0220","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-018-06086-4","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151363","article-title":"Inhibition of the myotoxicity induced by Bothrops jararacussu venom and isolated phospholipases A2 by specific camelid single-domain antibody fragments","volume":"11","author":"Prado","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112215","article-title":"Preclinical evaluation of single domain antibody efficacy in mitigating local tissue damage induced by Bothrops snake envenomation","volume":"134","author":"Prado","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0235","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fimmu.2020.00655","article-title":"Development of nanobodies against hemorrhagic and myotoxic components of Bothrops atrox snake venom","volume":"11","author":"Bailon Calderon","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41541-024-00900-5","article-title":"Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging","volume":"9","author":"Lemdani","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102083","article-title":"mRNA vaccine trafficking and resulting protein expression after intramuscular administration","volume":"35","author":"Hassett","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.toxicon.2016.08.007","article-title":"CoaTx-II, a new dimeric Lys49 phospholipase A2 from Crotalus oreganus abyssus snake venom with bactericidal potential: Insights into its structure and biological roles","volume":"120","author":"Almeida","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxicon.2021.01.003","article-title":"Changes in basement membrane components in an experimental model of skeletal muscle degeneration and regeneration induced by snake venom and myotoxic phospholipase A2","volume":"192","author":"Escalante","year":"2021","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2015.07.334","article-title":"Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score","volume":"104","author":"Laustsen","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.tibtech.2025.10.017_bb0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbt.2017.05.005","article-title":"Guiding recombinant antivenom development by omics technologies","volume":"45","author":"Laustsen","year":"2018","journal-title":"New Biotechnol."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0270","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/abio.1998.2914","article-title":"RNA quantitation by fluorescence-based solution assay: RiboGreen reagent characterization","volume":"265","author":"Jones","year":"1998","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tibtech.2025.10.017_bb0275","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1172\/JCI91445","article-title":"Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy","volume":"127","author":"Quattrocelli","year":"2017","journal-title":"J. Clin. Invest."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779925004457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779925004457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:13:59Z","timestamp":1773915239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779925004457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0167779925004457"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2025.10.017","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramuscular delivery of mRNA-encoded single-chain variable fragments prevents myotoxin II-induced skeletal muscle damage in a preclinical model","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2025.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}